Senior insider sale
CEO and President at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$281.9K
17.50K shares
What this filing means
STENGONE CARMINE N. plans to sell 17.50K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $281.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2026ACC: 0001950047-26-009206
DirectorOfficer· CEO and President
Since Feb 2026
17.50K
Shares to sell
$281.9K
Approx. market value
2.50K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/8/2026
2.50KTotal acquired2.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2026 | Exercise of Stock Options Cash | 2.50K | — |
| Total | 2.50K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
2.50K
Market value
$40.0K
8/3/2026
—Completed
Units to sell
2.50K
Market value
$40.0K
7/8/2026
—Completed
Units to sell
10K
Market value
$160.1K
6/30/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.50K
Market value
$41.8K
9/8/2026
Total
Units
17.50K
Value
$281.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/3/2026 | 2.50K | $40.0K | — | Completed |
7/8/2026 | 2.50K | $40.0K | — | Completed |
6/30/2026 | 10K | $160.1K | — | Completed |
| Planned — Approximate Date | ||||
9/8/2026 | 2.50K | $41.8K | NASDAQ | Planned |
| Total | 17.50K | $281.9K | ||